The Lenacapavir PrEP Rollout offers six-month HIV protection, but aid cuts and clinic access gaps raise concerns for high-risk groups.
Lenacapavir PrEP Rollout Brings Hope Amid Service Cuts
Original Article by Amy Green | Spotlight | 12 May 2026
The Lenacapavir PrEP Rollout offers six-month HIV protection, but aid cuts and clinic access gaps raise concerns for high-risk groups.
More Posts
Mpox Cases in SA Rise as Local Transmission Accelerates
Mpox cases in South Africa are rising, mainly in the Western Cape. What the surge means for the healthcare industry.
Read more...
NHLS Scrambles as Pathology Services Funding Runs Dry
The NHLS is scrambling for new providers after funds for haematology pathology services ran dry, amid an R11.3bn provincial debt
Read more...
Momentum Group Posts Record Earnings
Momentum Group has posted record earnings, with normalised headline earnings up 13% to R7.06bn – beating its R7bn Impact target a year early.
Read more...